Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Merger and Acquisition Activity Remains Buoyant in 2002

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Merger and Acquisition Activity Remains Buoyant in 2002. Pharmaceutical Innovation 12, 19–22 (2003). https://doi.org/10.1007/BF03265464

    Download citation

    Keywords

    • Filgrastim
    • Pegfilgrastim
    • Biotech Company
    • Marketing Capability
    • Pharmaceutical Sector